| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1477-1487, Copyright © 1995 by Endocrine Society
ARTICLES |
Z Liu, DW Mittanck, S Kim and P Rotwein
Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, Saint Louis, Missouri 63110, USA.
The insulin-like growth factor-II/cation-independent mannose 6- phosphate receptor (IGF-II/MPR) is a multifunctional protein that binds IGF-II and ligands containing a mannose 6-phosphate recognition marker. Recent studies have shown that this receptor plays a critical role in mammalian development, and that its expression is controlled by both epigenetic and tissue-specific factors. Our laboratory has cloned the 93-kilobase mouse gene and characterized its 48 exons. In this report we describe the structure and function of the IGF-II/MPR gene promoter. To study promoter function, a series of chimeric plasmids linking different segments of IGF-II/MPR 5' flanking DNA to the reporter gene, firefly luciferase, were transiently transfected into HepG2 and C3H 10T1/2 cells. Promoter activity was orientation-specific and was maximal (550- to 4250-fold above promoterless control) with a plasmid containing 266 base pairs (bp) of IGF-II/MPR DNA. The fusion gene accurately directed transcription as measured by ribonuclease protection assay using RNA extracted from transfected cells. DNA- protein binding studies by in vitro DNase I footprinting revealed an extended 54-bp footprint within the proximal promoter that contained two E-boxes and potential binding sites for transcription factors Sp1, NGF-IA, and related proteins. Gel mobility shift experiments with double-stranded oligonucleotides containing this region gave rise to several specific DNA-protein complexes, and the addition of specific antibodies indicated that proteins antigenically related to Sp1 and c- Myc were components of one or more of these bands. Deletion of this 54- bp segment led to an 8-fold decline in promoter activity, and its transfer to a heterologous promoter stimulated gene expression by nearly 7-fold. Mutational analyses indicated that each E box contributed to more than half of the enhancer's activity. These results define a strong minimal IGF-II/MPR promoter of no more than 266 bp and identify a 54-bp enhancer within this promoter fragment. Our observations thus represent a first step toward characterizing the developmental, epigenetic, and tissue-specific factors that control IGF- II/MPR gene expression.
This article has been cited by other articles:
![]() |
M. N. Szentirmay, H.-X. Yang, S. A. Pawar, C. Vinson, and M. Sawadogo The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer Cells J. Biol. Chem., September 26, 2003; 278(39): 37231 - 37240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, B. H. Davis, M. D. Sitrin, T. A. Brasitus, and M. Bissonnette Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3 Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G864 - G874. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Waguri, M. Kohmura, S. Kanamori, T. Watanabe, Y. Ohsawa, M. Koike, Y. Tomiyama, M. Wakasugi, E. Kominami, and Y. Uchiyama Different Distribution Patterns of the Two Mannose 6-phosphate Receptors in Rat Liver J. Histochem. Cytochem., November 1, 2001; 49(11): 1397 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text] |
||||
![]() |
J. A. Weiner, A. Chen, and B. H. Davis E-box-binding Repressor Is Down-regulated in Hepatic Stellate Cells during Up-regulation of Mannose 6-Phosphate/Insulin-like Growth Factor-II Receptor Expression in Early Hepatic Fibrogenesis J. Biol. Chem., June 26, 1998; 273(26): 15913 - 15919. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang and S. Melmed Identification of an Upstream Enhancer within a Functional Promoter of the Human Leukemia Inhibitory Factor Receptor Gene and Its Alternative Promoter Usage J. Biol. Chem., October 31, 1997; 272(44): 27957 - 27965. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |